RAPID RESPONSE: Exploring the Changes Hidden in the August 3, 2020 Final USPTO Fee Rules
October 15, 2020 12:30 PM to 2:00 PM
Exploring the Changes Hidden in the August 3, 2020 Final USPTO Fee Rules
The USPTO published a Final Rule for "Setting and Adjusting Patent Fees During Fiscal Year 2020" on August 3, 2020, in a Federal Register Notice, announcing fee changes that take effect October 2, 2020. However, the Final Rule contained more than just the usual fee raises. The Final Rule established three other important changes for patent practitioners that could be missed without a careful review, and went largely unnoticed by the patent community. This webinar will provide information about these changes that take effect starting in 2022, including a non-DOCX filing surcharge, a new biennial patent practitioner registration statement requirement, and a voluntary CLE certification for registered practitioners. Speakers will explore the details outlined in the August 3 Final Rule, details that still need clarification by the USPTO, and potential implications for patent applicants and practitioners.
Moderator:
Brian Stanton, Stanton Consulting Services
Speakers:
Terry Clark, Bass, Berry & Sims – Biennial Registration Statement
Theresa Stadheim, Mueting Raasch Group – Voluntary CLE Certification
Brad Forrest, Schwegman Lundberg & Woessner, P.A. – Non-DOCX Filing Surcharge
Add to:
News
-
Supreme Court Issues Unanimous Decision in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc.
June 4, 2026
On June 4, 2026, the Supreme Court issued a unanimous decision in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. While the Court reaffirmed existing law on pleading standards, it reversed the Federal Circuit’s decision that had focused on how relevant statements could be understood by medical providers as instructions to infringe. The amicus brief filed by AIPLA on March 27, 2026, advocated for affirmance and cautioned the Court not to change the patent infringement pleading standard or adopt any categorical exemption from inducement for a particular industry. -
AIPLA Views on H.R. 3269, the “ETHIC Act,” and H.R. 6485, the “Skinny Labels, Big Savings Act”
June 3, 2026
Arlington, VA. June 3, 2026 – The American Intellectual Property Law Association (AIPLA) submitted a letter to the House Judiciary Committee’s Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet outlining its views on H.R. 3269, the “ETHIC Act,” and H.R. 6485, the “Skinny Labels, Big Savings Act.” -
AIPLA Submits Comments to the USPTO on 2026 Supplemental GUI Guidance
May 15, 2026
Arlington, VA. May 12, 2026 – The American Intellectual Property Law Association (AIPLA) submitted comments to the USPTO on its Supplemental Guidance for Examination of Design Patent Applications Related to Computer-Generated Interfaces and Icons, issued on March 13, 2026. -
AIPLA Comments on the Copyright Office's Proposed Fee Schedule Adjustment
May 8, 2026
Arlington, VA. May 1, 2026 – The American Intellectual Property Law Association (AIPLA) submitted comments in response to the U.S. Copyright Office’s Notice of Proposed Rulemaking on adjustments to its fee schedule. -
AIPLA Submits Comments on the Enlarged Board of Appeal’s 11 Preliminary Opinion in G 1/25
May 1, 2026
Arlington, VA. April 17, 2026 – The American Intellectual Property Law Association (AIPLA) submitted comments on the Enlarged Board of Appeal’s 11 March 2026 preliminary opinion in G 1/25, addressing whether patent descriptions must be adapted following claim amendments.